Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00821496 · ClinicalTrials.gov registry record · Phase 1
Evaluate the Effect of VI-0521 on the Pharmacokinetics of Oral Contraceptive in Healthy Female Subjects
A Phase 1 study, sponsored by VIVUS.
- Completed
- Registry status
- Phase 1
- Development phase
- 20
- Enrollment target
NCT00821496 is a Phase 1 study that has completed, run by VIVUS. The registered enrollment target is 20 participants.
The verdict
NCT00821496, a Phase 1 study, has completed, sponsored by VIVUS.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 20 participants
- Enrollment target
Study Summary
This study is desgigned to look at the effect of multiple dosing administration of VI-0521 on Oral Contraceptive medication.
Interventions
- DRUG ethinyl estradiol, norethindrone, VI-0521
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2009-01 |
| Est. Completion | 2009-04 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00821496
The ClinicalTrials.gov registry entry for NCT00821496 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VIVUS, which has 35 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ethinyl estradiol, norethindrone, VI-0521 is the first listed.
NCT00821496 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00821496 about?
NCT00821496 is a clinical study titled "Evaluate the Effect of VI-0521 on the Pharmacokinetics of Oral Contraceptive in Healthy Female Subjects". This study is desgigned to look at the effect of multiple dosing administration of VI-0521 on Oral Contraceptive medication.
What is the current status of trial NCT00821496?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 20 participants. The study started on 2009-01. Estimated completion is 2009-04.
What interventions are being tested in trial NCT00821496?
The interventions under investigation include: ethinyl estradiol, norethindrone, VI-0521 (DRUG).
Who is sponsoring clinical trial NCT00821496?
This trial is sponsored by VIVUS, which has 35 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.